Skip to main content
Erschienen in: Journal of General Internal Medicine 5/2018

06.02.2018 | Original Research

Hospital-Level Care at Home for Acutely Ill Adults: a Pilot Randomized Controlled Trial

verfasst von: David M. Levine, MD MPH MA, Kei Ouchi, MD MPH, Bonnie Blanchfield, ScD, Keren Diamond, RN MBA, Adam Licurse, MD MHS, Charles T. Pu, MD, Jeffrey L. Schnipper, MD MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Hospitals are standard of care for acute illness, but hospitals can be unsafe, uncomfortable, and expensive. Providing substitutive hospital-level care in a patient’s home potentially reduces cost while maintaining or improving quality, safety, and patient experience, although evidence from randomized controlled trials in the US is lacking.

Objective

Determine if home hospital care reduces cost while maintaining quality, safety, and patient experience.

Design

Randomized controlled trial.

Participants

Adults admitted via the emergency department with any infection or exacerbation of heart failure, chronic obstructive pulmonary disease, or asthma.

Intervention

Home hospital care, including nurse and physician home visits, intravenous medications, continuous monitoring, video communication, and point-of-care testing.

Main Measures

Primary outcome was direct cost of the acute care episode. Secondary outcomes included utilization, 30-day cost, physical activity, and patient experience.

Key Results

Nine patients were randomized to home, 11 to usual care. Median direct cost of the acute care episode for home patients was 52% (IQR, 28%; p = 0.05) lower than for control patients. During the care episode, home patients had fewer laboratory orders (median per admission: 6 vs. 19; p < 0.01) and less often received consultations (0% vs. 27%; p = 0.04). Home patients were more physically active (median minutes, 209 vs. 78; p < 0.01), with a trend toward more sleep. No adverse events occurred in home patients, one occurred in control patients. Median direct cost for the acute care plus 30-day post-discharge period for home patients was 67% (IQR, 77%; p < 0.01) lower, with trends toward less use of home-care services (22% vs. 55%; p = 0.08) and fewer readmissions (11% vs. 36%; p = 0.32). Patient experience was similar in both groups.

Conclusions

The use of substitutive home-hospitalization compared to in-hospital usual care reduced cost and utilization and improved physical activity. No significant differences in quality, safety, and patient experience were noted, with more definitive results awaiting a larger trial.
Trial Registration NCT02864420.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
7.
Zurück zum Zitat Leff B, Burton L, Mader SL, et al. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med 2005;143(11):798-808.CrossRefPubMed Leff B, Burton L, Mader SL, et al. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med 2005;143(11):798-808.CrossRefPubMed
13.
Zurück zum Zitat Board N, Brennan N, Caplan GA. A randomised controlled trial of the costs of hospital as compared with hospital in the home for acute medical patients. Aust N Z J Public Health 2000;24(3):305-311.CrossRefPubMed Board N, Brennan N, Caplan GA. A randomised controlled trial of the costs of hospital as compared with hospital in the home for acute medical patients. Aust N Z J Public Health 2000;24(3):305-311.CrossRefPubMed
15.
Zurück zum Zitat Caplan GA, Coconis J, Woods J. Effect of hospital in the home treatment on physical and cognitive function: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 2005;60(8):1035-1038.CrossRefPubMed Caplan GA, Coconis J, Woods J. Effect of hospital in the home treatment on physical and cognitive function: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 2005;60(8):1035-1038.CrossRefPubMed
16.
Zurück zum Zitat Montalto M. The 500-bed hospital that isn’t there: the Victorian Department of Health review of the Hospital in the Home program. Med J Aust 2010;193(10):598-601.PubMed Montalto M. The 500-bed hospital that isn’t there: the Victorian Department of Health review of the Hospital in the Home program. Med J Aust 2010;193(10):598-601.PubMed
22.
Zurück zum Zitat Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med 2004;36(8):588-594.PubMed Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med 2004;36(8):588-594.PubMed
29.
Zurück zum Zitat Caplan GA, Ward JA, Brennan NJ, Coconis J, Board N, Brown A. Hospital in the home: a randomised controlled trial. Med J Aust 1999;170(4):156-160.PubMed Caplan GA, Ward JA, Brennan NJ, Coconis J, Board N, Brown A. Hospital in the home: a randomised controlled trial. Med J Aust 1999;170(4):156-160.PubMed
Metadaten
Titel
Hospital-Level Care at Home for Acutely Ill Adults: a Pilot Randomized Controlled Trial
verfasst von
David M. Levine, MD MPH MA
Kei Ouchi, MD MPH
Bonnie Blanchfield, ScD
Keren Diamond, RN MBA
Adam Licurse, MD MHS
Charles T. Pu, MD
Jeffrey L. Schnipper, MD MPH
Publikationsdatum
06.02.2018
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 5/2018
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4307-z

Weitere Artikel der Ausgabe 5/2018

Journal of General Internal Medicine 5/2018 Zur Ausgabe

Clinical Practice: Clinical Images

An Unusual Cause of Horner Syndrome

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.